The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.


Updates from The Motley Fool

Latest updates on Parexel International from Fool.com.
3 Biotech Stocks to Buy on Sale

These biopharma stocks have great prospects and can be purchased today at attractive prices.

Investor Beat, Nov. 19, 2013

The top business stories on JPMorgan, Home Depot and Best Buy for today's Foolish investor.



Stock Performance

View Interactive PRXL Charts
Sponsored by

Key Data Points

Primary metrics and data points about Parexel International.
Current Price: $65.80
Prev Close: $66.19
Open: $66.06
Bid: $65.00
Ask: $68.87
Day's Range: $65.36 - $66.67
52wk Range: $51.16 - $72.32
Volume: 571,969
Avg Vol 1,185,513
Market Cap: $4B
P/E (ttm): 23.56
EPS (ttm): $2.81
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Parexel International.
CAPS Rating 5 out of 5
 
346 Outperform
12 Underperform
CAPS All Stars
 
93 Outperform
1 Underperform

How do you think Parexel International will perform against the market?



You pick for Parexel International is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Josef H. von Rickenbach, CEO

89% Approve

Based on 320 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Parexel International.

The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT